A Novel PMVK Variant Associated with Familial Porokeratosis
Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to i...
Saved in:
Published in | Human heredity Vol. 88; no. 1; pp. 50 - 57 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.01.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease. |
---|---|
AbstractList | Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease. Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis.BACKGROUNDPorokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis.The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity.OBJECTIVESThe aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity.In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted.METHODIn this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted.We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein.RESULTSWe identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein.The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.CONCLUSIONSThe novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease. Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the [alpha]-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease. Keywords: PMVK gene, Porokeratosis, Variation, Mevalonate pathway, Phosphomevalonate kinase Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease. |
Audience | Academic |
Author | Shao, Fengmin Shi, Lei Nie, Xinmiao Cao, Lihua Zhang, Wenjing |
Author_xml | – sequence: 1 givenname: Wenjing surname: Zhang fullname: Zhang, Wenjing – sequence: 2 givenname: Xinmiao surname: Nie fullname: Nie, Xinmiao – sequence: 3 givenname: Lei surname: Shi fullname: Shi, Lei – sequence: 4 givenname: Fengmin surname: Shao fullname: Shao, Fengmin email: *Fengmin Shao, fengminshao@126.com, Lihua Cao, lhcao@cmu.edu.cn – sequence: 5 givenname: Lihua orcidid: 0000-0002-0795-0397 surname: Cao fullname: Cao, Lihua email: *Fengmin Shao, fengminshao@126.com, Lihua Cao, lhcao@cmu.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37315547$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0UtLxDAQAOAgiq6Pg3eRwl70UM2jSVs8LaKu-Dyo1zCmU422zZp0Ff-9keqCIHMImXwzhJl1sty5DgnZZvSAMVkeUkqlYIzTJTJiGRcppYovk1HMs1QqydfIeggv8VrQXKySNZELJmWWj8jRJLl279gkt1cPF8kDeAtdn0xCcMZCj1XyYfvn5BRa21iIynn3ih56F2zYJCs1NAG3fs4Ncn96cnc8TS9vzs6PJ5epEaXqU5NVMXhmSlHQWqpalgAFpVlBDTBZVKyqeYGoSngsQVGslFIGJaic8bxQYoPsDX1n3r3NMfS6tcFg00CHbh40L7jiTAnBIh0P9Aka1LarXe_BfHM9yfNccVFSEdXBPypGha01cba1jfk_BftDgfEuBI-1nnnbgv_UjOrvFejFCqLd_fnt_LHFaiF_Zx7BzgBewT-hX4BF_fjf5-n0ZBB6VtXiCwtdk1I |
ContentType | Journal Article |
Copyright | 2023 The Author(s). Published by S. Karger AG, Basel 2023 The Author(s). Published by S. Karger AG, Basel. COPYRIGHT 2023 S. Karger AG |
Copyright_xml | – notice: 2023 The Author(s). Published by S. Karger AG, Basel – notice: 2023 The Author(s). Published by S. Karger AG, Basel. – notice: COPYRIGHT 2023 S. Karger AG |
DBID | M-- CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1159/000531120 |
DatabaseName | Karger Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: M-- name: Karger Open Access url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1423-0062 |
EndPage | 57 |
ExternalDocumentID | A777623903 10_1159_000531120 37315547 531120 |
Genre | News |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0~B 29I 326 36B 3O. 4.4 5GY 5RE 7X7 8UI AAYIC ABJNI ABPAZ ABUWG ACGFS ACGOD ACPRK ACPSR ADBBV AENEX AEYAO AHMBA ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS AZPMC AZQEC BBNVY BENPR BHPHI BPHCQ CS3 CYUIP DU5 DWQXO E0A EBS EMB EMOBN F5P FB. FYUFA GNUQQ GUQSH HCIFZ HZ~ IAO IGS IHR INH IY7 KUZGX L7B M-- M1P M2O M2P M7P N9A O1H O9- OK1 RKO SV3 UJ6 .GJ 0~5 30W 34G 39C 3V. 53G 88A 88E 88I 8AO 8FE 8FH 8FI 8FJ 8FW 8G5 ABBHK ABXSQ ADACV ADAGL ADULT AEJYH AFFNX AFJJK AFKRA AI. AILCM AIOBO BVXVI CAG CCPQU CGR COF CUY CVF ECM EIF EJD HMCUK ITC JAAYA JENOY JKPJF JPL JPM JSODD JST JVCUD LK8 M0L NPM PQQKQ PROAC PSQYO RIG RXVBD SA0 UKHRP VH1 ZGI ZXP AAYXX CITATION 0R~ AAKET ABZSI ACHQM ZA5 7X8 |
ID | FETCH-LOGICAL-c396t-c4d4d424c9380f56f59aa800480ca158d1df28ee69ab9a60ed666ce5a67127863 |
IEDL.DBID | M-- |
ISSN | 0001-5652 1423-0062 |
IngestDate | Fri Nov 08 20:42:24 EST 2024 Fri Feb 23 00:19:39 EST 2024 Fri Feb 02 04:33:44 EST 2024 Wed Sep 18 12:52:42 EDT 2024 Sat Nov 02 12:28:02 EDT 2024 Thu Aug 29 12:04:36 EDT 2024 Thu Sep 05 20:30:46 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | PMVK gene Porokeratosis Variation Phosphomevalonate kinase Mevalonate pathway |
Language | English |
License | This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. 2023 The Author(s). Published by S. Karger AG, Basel. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c396t-c4d4d424c9380f56f59aa800480ca158d1df28ee69ab9a60ed666ce5a67127863 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-News-1 content type line 23 |
ORCID | 0000-0002-0795-0397 |
OpenAccessLink | https://karger.com/doi/10.1159/000531120 |
PMID | 37315547 |
PQID | 2826216331 |
PQPubID | 23479 |
PageCount | 8 |
ParticipantIDs | crossref_primary_10_1159_000531120 gale_infotracacademiconefile_A777623903 pubmed_primary_37315547 karger_primary_531120 gale_infotracmisc_A777623903 proquest_miscellaneous_2826216331 |
PublicationCentury | 2000 |
PublicationDate | 2023-01-01 |
PublicationDateYYYYMMDD | 2023-01-01 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland |
PublicationTitle | Human heredity |
PublicationTitleAlternate | Hum Hered |
PublicationYear | 2023 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Song NJ, Luan J, Zhang ZH. Updating and identifying a novel mutation in the PMVK gene in classic porokeratosis of Mibelli. Clin Exp Dermatol. 2017;42(8):910–1. Shi WH, Fu XA, Wang ZZ, Mi ZH, Zhang H, Yu GQ. Twenty-two novel mutations in a Chinese cohort of 137 patients with porokeratosis were identified using microfluidics (Fluidigm). J Dermatol Sci. 2021;101(1):75–7. Tee SI, Chong WS. Eruptive pruritic papular porokeratosis. Indian J Dermatol Venereol Leprol. 2012;78(6):758–60. Kanitakis J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur J Dermatol. 2014;24(5):533–44. Chambliss KL, Slaughter CA, Schreiner R, Hoffmann GF, Gibson KM. Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence. J Biol Chem. 1996;271(29):17330–4. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 201240Database issueD10914. Leng YJ, Yan LL, Feng HQ, Chen C, Wang SS, Luo Y. Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis. J Dermatol. 2018;45(7):862–6. Jägle S, Juratli HA, Hickman G, Süssmuth K, Boente MC, Kopp J. Porokeratosis Plantaris, Palmaris et Disseminata caused by con- genital pathogenic variants in the MVD gene and loss of hetero-zygosity in affected skin. Acta Derm Venereol. 20211012adv00397. McGuigan K, Shurman D, Campanelli C, Lee JB. Porokeratosis ptychotropica: a clinically distinct variant of porokeratosis. J Am Acad Dermatol. 2009;60(3):501–3. Liu Y, Wang JX, Qin YY, Huang CZ, Archacki S, Ma JJ. Identification of three mutations in the MVK gene in six patients associated with disseminated superficial actinic porokeratosis. Clin Chim Acta. 2016;454:124–9. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24. Li M, Li Z, Wang J, Ni C, Sun Z, Wilson NJ. Mutations in the mevalonate pathway genes in Chinese patients with porokeratosis. J Eur Acad Dermatol Venereol. 2016;30(9):1512–7. Rahbari H, Cordero AA, Mehregan AH. Punctate porokeratosis. A clinical variant of porokeratosis of Mibelli. J Cutan Pathol. 1977;4(6):338–41. Ferreira FR, Santos LD, Tagliarini FA, Lira ML. Porokeratosis of Mibelli--literature review and a case report. An Bras Dermatol. 2013886 Suppl 117982. Wang JX, Liu Y, Liu F, Huang CZ, Han SS, Lv YX. Loss-of-function mutation in PMVK causes autosomal dominant disseminated superficial porokeratosis. Sci Rep. 2016;6:24226. Atzmony L, Khan HM, Lim YH, Paller AS, Levinsohn JL, Holland KE. Second-hit, postzygotic PMVK and MVD mutations in linear porokeratosis. JAMA Dermatol. 2019;155(5):548–55. Chang Q, Yan XX, Gu SY, Liu JF, Liang DC. Crystal structure of human phosphomevalonate kinase at 1.8 A resolution. Proteins. 2008;73(1):254–8. Sertznig P, von Felbert V, Megahed M. Porokeratosis: present concepts. J Eur Acad Dermatol Venereol. 2012;26(4):404–12. Allegra F. The man behind the eponym. Vittorio Mibelli and the tale of “porokeratosis”. Am J Dermatopathol. 1986;8(2):169–72. Anderson DE, Chernosky ME. Disseminated superficial actinic porokeratosis. Genetic aspects. Arch Dermatol. 1969;99(4):408–12. Commens CA, Shumack SP. Linear porokeratosis in two families with disseminated superficial actinic porokeratosis. Pediatr Dermatol. 1987;4(3):209–14. Brasch J, Scheuer B, Christophers E. Porokeratosis plantaris, palmaris et disseminata. Hautarzt. 1985;36(8):459–61. Olivier LM, Chambliss KL, Gibson KM, Krisans SK. Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. J Lipid Res. 1999;40(4):672–9. Zhang ZH, Li CH, Wu F, Ma RX, Luan J, Yang F. Genomic variations of the mevalonate pathway in porokeratosis. Elife. 2015;4:e06322. |
References_xml | |
SSID | ssj0008073 |
Score | 2.37375 |
Snippet | Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes,... Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including... |
SourceID | proquest gale crossref pubmed karger |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 50 |
SubjectTerms | Amino acids Analysis Brief Report DNA sequencing Enzymes Ethylenediaminetetraacetic acid Genetic aspects Humans Hydrogen Mutation Mutation, Missense Nucleotide sequencing Pedigree Phosphotransferases (Phosphate Group Acceptor) - genetics Porokeratosis - genetics Skin Skin diseases |
Title | A Novel PMVK Variant Associated with Familial Porokeratosis |
URI | https://karger.com/doi/10.1159/000531120 https://www.ncbi.nlm.nih.gov/pubmed/37315547 https://www.proquest.com/docview/2826216331 |
Volume | 88 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3da9swED_adC15KV3brV7ToI3BngyWZX3Rp6ykhI2EMNaSN6NIMpSOuCTpoP99T_6CFIrfLFkHd2fd_fTxO4DvRmaq8JmNuVzyOLOaxoZahSjFMy6tdKri7pzOxOQu-7Xgi2a9I9yFeQznnytq1I5bAANuVXqOYWqA4PwglSILMGsax92cq5JmLxnBMaYoacMhtPNpH46YZCF-yp0g1EzFH2rR72eaVcS5PYHjJlUko9q2H2HPr07hsC4e-XIKR9NmW_wMrkdkVv73_8h8ev-b3CP8RX2RVvPekbDaSqoaF-huZF6uy8dAplxuHjbncHc7_nsziZuqCLFlWmxjmzl8UlQrU0nBRcG1Maq6G24N5cpRV6TKe6HNUhuReIcIxXpuhKSpVIJ9gt6qXPkLIIhWXGoKiQ02o0ortaSJoz4xUlutdATfWjXlTzX5RV6BBq7zTq0R_AgKzMMPsV0ba5pz_SgiUEvlIylxwmU6YREMdnqiI9ud5vPaBJ2sVsDgzfvJZFw35U-uiOBra7A8jBgOja18-bzJEU2KFPNNRiP4XFuyG6L1hC_vCL2EfigsXy-2DKC3XT_7K0w_tssh7MuFHMLBz_Fs_mdY-eErBULPOg |
link.rule.ids | 315,783,787,27647,27936,27937,31732,33757 |
linkProvider | Karger AG |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Novel+PMVK+Variant+Associated+with+Familial+Porokeratosis&rft.jtitle=Human+heredity&rft.au=Zhang%2C+Wenjing&rft.au=Nie%2C+Xinmiao&rft.au=Shi%2C+Lei&rft.au=Shao%2C+Fengmin&rft.date=2023-01-01&rft.pub=S.+Karger+AG&rft.issn=0001-5652&rft.eissn=1423-0062&rft.volume=88&rft.issue=1&rft.spage=50&rft_id=info:doi/10.1159%2F000531120&rft.externalDocID=A777623903 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-5652&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-5652&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-5652&client=summon |